Figure 2From: Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational studyAdjusted Kaplan-Meier curves for the primary composite endpoint (vascular death, non-fatal myocardial infarction and non-fatal stroke) in the primary and secondary prevention cohorts, stratified by aspirin usage during the observational period.Back to article page